As of Oct 18
| -0.33 / -0.71%|
The 22 analysts offering 12-month price forecasts for Sanofi SA have a median target of 50.99, with a high estimate of 55.70 and a low estimate of 43.80. The median estimate represents a +10.43% increase from the last price of 46.17.
The current consensus among 24 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.